Study of EB-101 for the Treatment of Recessive Dystrophic Epidermolysis Bullosa
Condition: Recessive Dystrophic Epidermolysis Bullosa Intervention: Biological: EB-101 Sponsors: Jean Yuh Tang; Abeona Therapeutics, Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Epidermolysis Bullosa | Study